Ernexa Therapeutics Inc. - Common Stock, par value $0.005 per share (ERNA) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2022 to Q2 2025

Type / Class
Equity / Common Stock, par value $0.005 per share
Symbol
ERNA on Nasdaq
Shares outstanding
110,002,045
Price per share
$0.21
Price from insider filings
$0.21
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Ernexa Therapeutics Inc. - Common Stock, par value $0.005 per share (ERNA) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Cherington Charles 38% +15% $8,755,063 +$4,464,210 41,690,775 +104% Charles Cherington 09 Jun 2025
Freebird Partners LP 9.9% -0.9% $1,180,191 +$204,218 6,211,530 +21% Freebird Partners LP 31 Mar 2025
HALPERN JOHN D 9.6% -3.9% $1,254,084 +$175,402 5,971,830 +16% John D. Halpern 31 Mar 2025
Konar Shameek 5.5% $652,708 3,435,304 Shameek Konar 31 Mar 2025
IAF, LLC 5.2% -0.4% $618,530 +$109,479 3,255,421 +22% IAF, LLC 31 Mar 2025
Singer Nicholas Jason 4.9% $487,350 2,565,001 Nicholas Jason Singer 31 Dec 2024

Institutional Holders of Ernexa Therapeutics Inc. - Common Stock, par value $0.005 per share (ERNA) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q2 0 $0 -$264,172 $0.21 0
2025 Q1 1,488,385 $264,200 +$76,046 $0.18 26
2024 Q4 994,393 $292,358 +$69,709 $0.29 24
2024 Q3 711,299 $746,882 +$337,331 $1.05 20
2024 Q2 390,079 $712,390 -$24,972 $1.83 19
2024 Q1 10,165 $25,270 +$25,115 $2.40 4
2023 Q4 354,989 $636,865 +$42,245 $1.80 18
2023 Q3 331,434 $728,396 -$4,855 $2.18 19
2023 Q2 333,250 $750,186 -$15,587 $2.26 19
2023 Q1 331,798 $1,135,164 +$6,895 $3.40 19
2022 Q4 250,194 $805,127 +$608,097 $3.22 17